講座メンバー

趙 琦 (Qi Zhao)
特命助教

現在の研究テーマ(current research project)

シナプス・分子レベルについて記憶の再固定化の研究

抱負(ambitious future plan)

世界中に一流な研究を遣りたい。

専門分野 (background scientific field)

行動薬理学・神経薬理学

略 歴(personal history)

医学修士、薬学博士
1983年7月 中国・長春中医薬大学医学部卒業
1983年9月~1988年7月 中国・長春中医薬大学・助手
1991年9月~1998年10月 中国・長春中医薬大学・ 講師
1998年10月~1999年10月 中国政府国費留学生ー富山医科薬科大学和漢薬研究所生物試
験部門客員研究員
2000年2月~2012年3月 富山医科薬科大学和漢薬総合研究所複合薬物薬理学技術補佐員、研究員、ポスドク研究員など
2012年4月~2013年3月 富山大学医学部 生化学講座 技術補佐員
2013年9月~現在 富山大学医学部 生化学講座 特命助教

業 績(publications)

  • 1. Tohda M., Zhao Q., Watanabe H.
    Influence of Chronic Treatment With Imipramine on mRNA Levels in Rat Brain: Elevation of Glyceraldehyde-3-phosphate Dehydrogenase Levels.
    Jpn. J. Pharmacol., 81, 393-396, 1999.
  • 2. Watanabe H., Zhao Q., Matsumoto K., Tohda M., Murakami Y., Zhang S.H., Kang T.H.,Mahakunakorn P., Maruyama Y., Sakakibara I., Aimi N., Takayama H.
    Pharmacological evidence for antidementia effect of Choto-san (Gouteng-san), a traditional Kampo medicine.
    Pharmacol, Biochem. Behav., 75, 635-643, 2003.
  • 3. Hussein G., Zhao Q., Nakamura M., Iguchi T., Goto H., Sankawa U., Watanabe H.
    Antihypertensive and neuroprotective effects of astaxanthin in experimental animals.
    Biol. Pharm. Bull., 28, 47-52, 2005.
  • 4. Zhao Q., Murakami Y., Tohda M., Watanabe H., Matsumoto K.
    Preventive effect of chotosan, a Kampo medicine, on transient ischemia-induced learning deficit is mediated by stimulation of muscarinic M1 but not nicotinic receptor.
    Biol. Pharm. Bull., 28, 1873-1878, 2005.
  • 5. Hussein G., Nakamura M., Zhao Q., Iguchi T., Goto H., Sankawa U., Watanabe H. Antihypertensive and neuroprotective effects of astaxanthin in experimental animals.
    Biol. Pharm. Bull., 28, 47-52, 2005.
  • 6. Zhao Q., Murakami Y., Tohda M., Obi R., Shimada Y., Matsumoto K.
    Chotosan, a Kampo formula, ameliorates chronic cerebral hypoperfusion-induced deficits in object recognition behaviors and central cholinergic systems in mice.
    J. Pharmacol. Sci., 103, 360-373, 2007.
  • 7. Obi R., Tohda M., Zhao Q., Obi N., Murakami Y., Goto H., Shimada Y., Ochiai H., Matsumoto K.
    Chotosan enhances macrophage colony-stimulating factor mRNA expression in the ischemic rat brain and C6Bu-1 glioma cells.
    Biol. Pharm. Bull., 30, 2250-2256, 2007.
  • 8. Zhao Q., Okada H., Ichiki H and Matsumoto K.
    Anti-hypertensive and anti-stroke effects of Chrysanthemum extracts in stroke-prone spontaneously hypertensive rats.
    J.Trad. Med., 25, 143-151, 2008.
  • 9. Cui H.S., Matsumoto K., Murakami Y., Hori H., Zhao Q., Obi R.
    Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures: involvement of B-cell lymphoma 2 phosphorylation suppression.
    Biol. Pharm. Bull., 32, 79-85, 2009.
  • 10. Zhao Q., Yokozawa T., Yamabe N., Tsuneyama K., Li X.H., Matsumoto K.
    Kangen-karyu improves memory deficit caused by aging through normalization of neuro-plasticity-related signaling system and VEGF system in the brain.
    J. Ethnopharmacol., 131, 377-385, 2010.
  • 11. Zhao Q., Yokozawa T., Tsuneyama K., Tanaka K., Miyata T., Shibahara N., and Kinzo Matsumoto K.
    Chotosan-induced improvement of cognitive deficits in senescence-accelerated mouse (SAMP8) involves normalization of angiogenic/neurotrophic factors and neuroplasticity systems in the brain.
    Chin Med., 23,1-18,2011
  • 12. Zhao Q., Matsumoto K., Tsuneyama K., Tanaka K., Li F., Shibahara N., Takeshi Miyata T., Yokozawa T.
    Diabetic-induced central cholinergic neuronal loss and cognitive deficit is reversed by tacrine and a Chinese herbal prescription Kangen-karyu: elucidation in a type 2 diabetic db/db mice.
    J. Pharmacol. Sci.117(4), 230-42, 2011.

趣味・特技(hobby, specialty)

推理小説を読む、演歌を聞く、相撲を見る、中華料理が得意。